Anna Törner: ”Drug prices – an important driver of innovation”

We live under the illusion that no price is too high when it comes to health, but that simply isn’t true, writes Anna Törner.

“Ozempic babies” – myth or reality?

Have weight-loss drugs such as Ozempic led to a rise in unplanned pregnancies? Life Science Sweden takes a closer look.

Insurance in Life Science: From risk to resilience

Are you visiting The Future of Swedish & Danish Life Science event in Lund 23 April? Don't miss the Gallagher seminar on Risk and Insurance in the Life Sciences sector.

Thermo Fisher Expands in Sweden – “We Are Sending a Clear Message”

The American life science giant Thermo Fisher Scientific has inaugurated a new distribution center in Uppsala. “By investing in increasing our capacity as well ...

“The US matters most – even in times of turbulence”

Tariffs, geopolitical uncertainty and rapidly changing trade conditions mean that Swedish life science companies need more routes into global markets – and fast...

Finland leads the way in the hunt for international top researchers

Several Nordic initiatives are currently under way to recruit international top researchers. Finland is making its largest national investment ever in attractin...

More than 150 jobs cut as Merck scales back vaccin production

Merck & Co, known as MSD in Europe, is hitting the brakes following a sharp decline in demand for its HPV vaccine Gardasil. Production at its facility in Durham...

Painkiller cuts recurrence risk by more than 50% – national guidelines updated

Sweden’s national guidelines for colon and rectal cancer have been updated — just nine months after the previous revision. The move follows new Swedish research...

End of bone‑sawing? New laser cuts to record depths

Saw, drill and chisel are a bone surgeon’s best friends today – but soon the laser may also find its place in that toolbox. Researchers in Switzerland have disc...

Novo Nordisk tells staff to return to office

At the turn of the year, Novo Nordisk employees will no longer be able to work remotely. According to the company’s new CEO, the move is intended to accelerate ...

A healthy society requires more than a new pill

Sarah Lidé on how medicines are essential – but a sustainable approach to healthy societies also depends on prevention and behavioural change

Investor Network Backs Early-Stage Nordic Innovation

Life Science Invest is expanding into the Nordic region and has secured SEK 31 million to invest in early-stage research companies. The capital will be invested...

Novo Nordisk Foundation commits billions to Danish life science incubator

The Novo Nordisk Foundation grants up to DKK 5.5 billion to life science and deep‑tech incubator Bioinnovation Institute (BII) in Copenhagen.

FDA leaders seek to scrap two-study requirement

A single pivotal study may be sufficient to secure approval for a new medicine in the United States. That is the message delivered by FDA Commissioner Marty Mak...

Asgard teaches tumours to self‑destruct – moving closer to clinical trials

Swedish biotech Asgard Therapeutics not only has an evocative name, but also a remarkably exciting approach to cancer treatment: getting tumour cells to reprogr...

Novo Nordisk strengthens board after turbulent year

Changes to Novo Nordisk’s board continue. Following last year’s sweeping restructuring, the Danish obesity drugmaker is now nominating two new directors with ex...

Dying man saved by artificial lung system

An external artificial lung system kept a critically ill man alive for two days until he could undergo a lung transplant. In the longer term, researchers hope t...

Come see us at the upcoming events!

We have some upcoming events where you can see our latest products live!

We desire talent to come here, but are we genuinely welcoming them?

Sweden faces significant challenges in creating a truly inclusive environment that makes international professionals feel welcome, valued, and able to build mea...

Sprint Bioscience builds the molecules that will become new medicines

In Sprint Bioscience’s laboratory in Flemingsberg, Huddinge, molecules are being created that no one has ever built before. The company specializes in preclinic...

Swedish drug development projects in Phase III – studies to keep an eye on

Developing new medicines is, as we know, a lengthy and uncertain process, and only a fraction of all projects ever reach late clinical phase. But it does happen...

Merck Life Science A/S

Breakthrough devices: Key insights from MDCG 2025-9 guidance

The Medical Device Coordination Group (MDCG) has published guidance MDCG 2025-9 to streamline the pathway for breakthrough devices (BtX) under the EU Medical De...

Heart Monitoring in Breast Cancer – Essential or Excessive?

Trastuzumab and related drugs have transformed breast cancer treatment and dramatically improved survival rates. But the close cardiac monitoring required durin...